Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated application pharmacokinetics and safety study of flurbiprofen patch LC1702 in healthy adult males
jRCT2031240583Phase 1Active, not recruiting
- Sponsor
- Lead Chemical
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of flurbiprofen in pain and inflammation, sponsored by Lead Chemical. Primary endpoint: Primary: Plasma concentration of flurbiprofen. Started Jan 2025; status: active, not recruiting.
02
Drugs
flurbiprofen
03
Conditions
paininflammation
Beyond the preview
Go deeper on jRCT2031240583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240583.